Watch Our Webinar

Analyzing the OIG Special Fraud Alert on Speaker Programs

Watch Now

About the Webinar:

In November 2020, the U.S. Department of Health and Human Services Office of Inspector General (OIG) issued a Special Fraud Alert that draws attention to potential fraud and abuse risks for speaker programs.

Life Sciences companies can utilize this guidance to evaluate their speaker remuneration in light of the risks highlighted in the Special Fraud Alert.  This webinar will analyze the Special Fraud Alert followed by a Q&A session.

Key Takeaways:

  • Analysis of the Special Fraud Alert guidance in conjunction with Anti-Kickback Statute enforcement of speaker programs
  •  Framework to evaluate current speaker programs based on risks highlighted in the Special Fraud Alert
  •  A walk-through of potential fraud or abuse legal theories
  • Key considerations for speaker programs to reduce fraud and abuse risks
  • Implications of Special Fraud Alert for the Life Sciences industry

Who Should Attend:

Legal and compliance professionals, consultants dealing with Compliance Monitoring and/or HCP engagement at drug or medical device manufacturing companies.

Meet Our Expert Speakers

Mohammad Ovais

Mohammad Ovais

Founder & CEO at qordata

Leslie Restaino

Leslie Restaino

Founder, Axios Life Sciences Compliance

Sarah diFrancesca

Sarah diFrancesca

Executive Director of Compliance

Watch Now

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.